Logo for University of Iowa Health Care This logo represents the University of Iowa Health Care

Current Studies

SwabCurrently Enrolling Studies

Pfizer C4781004 mRNA Influenza

A Phase 3, randomized, observer-blinded study to evaluate the efficacy, safety, tolerability, and immunogenicity of a modified RNA vaccine against influenza compared to licensed inactivated influenza vaccine in healthy adults 18 years of age or older. Currently enrolling ages 65+. 

To learn more, call 319-356-4848 or e-mail recruit-vaccine-research@uiowa.edu.

Ongoing Studies (Closed to Enrollment)


A Phase 2 clinical trial to optimize immune coverage of SARS-CoV-2 existing and emerging variants conducted by the Division of Microbiology and Infectious Diseases (DMID), National Institute of Allergy and Infectious Disease (NIAID), and National Institutes of Health (NIH).

DMID 20-0009 FluGen Pediatric Influenza

A Phase 1b, double-blind, randomized, dose-escalating, age de-escalating, placebo-controlled study to assess the safety and immunogenicity of one or two doses of Sing2016 M2SR H3N2 influenza vaccine delivered intranasally in a healthy pediatric population 6 months through 17 years of age.

Pfizer C3671013 RSV

A Phase 3 study to evaluate the efficacy, immunogenicity, and safety of Respiratory syncytial virus (RSV) prefusion F subunit vaccine in adults. 

Novavax 2019nCoV-301 COVID-19

A Phase 3, randomized, observer-blinded, placebo-controlled study to evaluate the efficacy, safety, and immunogenicity of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine with Matrix-M1TM adjuvant in adult participants 18 years or older.